Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Short term Debt (2016 - 2025)

Mimedx (MDXG) has disclosed Short term Debt for 9 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Short term Debt rose 50.0% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 50.0% year-over-year, with the annual reading at $1.5 million for FY2025, 50.0% up from the prior year.
  • Short term Debt hit $1.5 million in Q4 2025 for Mimedx, up from $1.4 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $1.5 million in Q4 2025 to a low of $1.0 million in Q4 2023.
  • Historically, Short term Debt has averaged $1.1 million across 3 years, with a median of $1.0 million in 2023.
  • Biggest five-year swings in Short term Debt: changed 0.0% in 2024 and later soared 50.0% in 2025.
  • Year by year, Short term Debt stood at $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then skyrocketed by 50.0% to $1.5 million in 2025.
  • Business Quant data shows Short term Debt for MDXG at $1.5 million in Q4 2025, $1.4 million in Q3 2025, and $1.2 million in Q2 2025.